The Link between Allergic Rhinitis and Asthma: A Role for Antileukotrienes? Journal Articles

abstract

• Allergic rhinitis and asthma are both chronic heterogeneous disorders, with an overlapping epidemiology of prevalence, health care costs and social costs in quality of life. Both are inflammatory disorders with a similar pathophysiology, and both share some treatment approaches. However, each disorder has an array of treatments used separately in controlling these atopic disorders, from inhaled corticosteroids, beta2‐agonists and antihistamines to newer monoclonal antibody‐based treatments. The present article reviews the shared components of allergic rhinitis and asthma, and examines recent evidence supporting antileukotrienes as effective agents in reducing the symptoms of both diseases.

authors

• Kim, Harold
• Bouchard, J
• Renzix, PM

status

• published 

publication date

• January 2008

has subject area

• Asthma (MeSH)
• Humans (MeSH)
• Leukotriene Antagonists (MeSH)
• Leukotrienes (MeSH)
• Prevalence (MeSH)
• Respiratory System (Science Metrix)
• Rhinitis, Allergic, Seasonal (MeSH)
• Risk Factors (MeSH)
• Treatment Outcome (MeSH)

published in

• Canadian Respiratory Journal  Journal

keywords

• Asthma
• Humans
• Leukotriene Antagonists
• Leukotrienes
• Prevalence
• Rhinitis, Allergic, Seasonal
• Risk Factors
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1155/2008/416095

start page

• 91

end page

• 98

volume

• 15

issue

• 2